BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38136588)

  • 1. ICF1-Syndrome-Associated
    Verma A; Poondi Krishnan V; Cecere F; D'Angelo E; Lullo V; Strazzullo M; Selig S; Angelini C; Matarazzo MR; Riccio A
    Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective demethylation and altered gene expression are associated with ICF syndrome in human-induced pluripotent stem cells and mesenchymal stem cells.
    Huang K; Wu Z; Liu Z; Hu G; Yu J; Chang KH; Kim KP; Le T; Faull KF; Rao N; Gennery A; Xue Z; Wang CY; Pellegrini M; Fan G
    Hum Mol Genet; 2014 Dec; 23(24):6448-57. PubMed ID: 25027325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The aberrant epigenome of
    Poondi Krishnan V; Morone B; Toubiana S; Krzak M; Fioriniello S; Della Ragione F; Strazzullo M; Angelini C; Selig S; Matarazzo MR
    Genome Res; 2023 Feb; 33(2):169-183. PubMed ID: 36828588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent epigenetic memory impedes rescue of the telomeric phenotype in human ICF iPSCs following DNMT3B correction.
    Toubiana S; Gagliardi M; Papa M; Manco R; Tzukerman M; Matarazzo MR; Selig S
    Elife; 2019 Nov; 8():. PubMed ID: 31738163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance of methylation profile in imprinting control regions in human induced pluripotent stem cells.
    Pham A; Selenou C; Giabicani E; Fontaine V; Marteau S; Brioude F; David L; Mitanchez D; Sobrier ML; Netchine I
    Clin Epigenetics; 2022 Dec; 14(1):190. PubMed ID: 36578048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cells as a model for telomeric abnormalities in ICF type I syndrome.
    Sagie S; Ellran E; Katzir H; Shaked R; Yehezkel S; Laevsky I; Ghanayim A; Geiger D; Tzukerman M; Selig S
    Hum Mol Genet; 2014 Jul; 23(14):3629-40. PubMed ID: 24549038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.
    Okano M; Bell DW; Haber DA; Li E
    Cell; 1999 Oct; 99(3):247-57. PubMed ID: 10555141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells.
    Tao Q; Huang H; Geiman TM; Lim CY; Fu L; Qiu GH; Robertson KD
    Hum Mol Genet; 2002 Sep; 11(18):2091-102. PubMed ID: 12189161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtelomeric methylation distinguishes between subtypes of Immunodeficiency, Centromeric instability and Facial anomalies syndrome.
    Toubiana S; Velasco G; Chityat A; Kaindl AM; Hershtig N; Tzur-Gilat A; Francastel C; Selig S
    Hum Mol Genet; 2018 Oct; 27(20):3568-3581. PubMed ID: 30010917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo DNA methylation by Dnmt3a and Dnmt3b is dispensable for nuclear reprogramming of somatic cells to a pluripotent state.
    Pawlak M; Jaenisch R
    Genes Dev; 2011 May; 25(10):1035-40. PubMed ID: 21576263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of hierarchical imprinting regulation at the Prader-Willi/Angelman syndrome locus in human iPSCs.
    Pólvora-Brandão D; Joaquim M; Godinho I; Aprile D; Álvaro AR; Onofre I; Raposo AC; Pereira de Almeida L; Duarte ST; da Rocha ST
    Hum Mol Genet; 2018 Dec; 27(23):3999-4011. PubMed ID: 30102380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing.
    Gatto S; Gagliardi M; Franzese M; Leppert S; Papa M; Cammisa M; Grillo G; Velasco G; Francastel C; Toubiana S; D'Esposito M; Angelini C; Matarazzo MR
    Nucleic Acids Res; 2017 Jun; 45(10):5739-5756. PubMed ID: 28334849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative methylome analysis of ICF patients identifies heterochromatin loci that require ZBTB24, CDCA7 and HELLS for their methylated state.
    Velasco G; Grillo G; Touleimat N; Ferry L; Ivkovic I; Ribierre F; Deleuze JF; Chantalat S; Picard C; Francastel C
    Hum Mol Genet; 2018 Jul; 27(14):2409-2424. PubMed ID: 29659838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Widespread recovery of methylation at gametic imprints in hypomethylated mouse stem cells following rescue with DNMT3A2.
    Thakur A; Mackin SJ; Irwin RE; O'Neill KM; Pollin G; Walsh C
    Epigenetics Chromatin; 2016; 9():53. PubMed ID: 27895716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function.
    Jin B; Tao Q; Peng J; Soo HM; Wu W; Ying J; Fields CR; Delmas AL; Liu X; Qiu J; Robertson KD
    Hum Mol Genet; 2008 Mar; 17(5):690-709. PubMed ID: 18029387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of DNMT3B homo-oligomer reveals vulnerability to impairment by ICF mutations.
    Gao L; Guo Y; Biswal M; Lu J; Yin J; Fang J; Chen X; Shao Z; Huang M; Wang Y; Wang GG; Song J
    Nat Commun; 2022 Jul; 13(1):4249. PubMed ID: 35869095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel
    Aminorroaya A; Rayzan E; Shahkarami S; Seyedpour S; Zoghi S; Aryan Z; Somekh I; Rohlfs M; Klein C; Esmaeilzadeh H; Rezaei N
    Endocr Metab Immune Disord Drug Targets; 2023; 23(3):410-415. PubMed ID: 35996251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA replication is altered in Immunodeficiency Centromeric instability Facial anomalies (ICF) cells carrying DNMT3B mutations.
    Lana E; Mégarbané A; Tourrière H; Sarda P; Lefranc G; Claustres M; De Sario A
    Eur J Hum Genet; 2012 Oct; 20(10):1044-50. PubMed ID: 22378288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome.
    Hansen RS; Wijmenga C; Luo P; Stanek AM; Canfield TK; Weemaes CM; Gartler SM
    Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14412-7. PubMed ID: 10588719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the mutation spectrum in ICF syndrome: Evidence for a gender bias in ICF2.
    van den Boogaard ML; Thijssen PE; Aytekin C; Licciardi F; Kıykım AA; Spossito L; Dalm VASH; Driessen GJ; Kersseboom R; de Vries F; van Ostaijen-Ten Dam MM; Ikinciogullari A; Dogu F; Oleastro M; Bailardo E; Daxinger L; Nain E; Baris S; van Tol MJD; Weemaes C; van der Maarel SM
    Clin Genet; 2017 Oct; 92(4):380-387. PubMed ID: 28128455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.